Through growth and profitability, SCA shall create increased value for its stakeholders. The strategy to accomplish this is to develop and launch products with high value-added content and to increase sales in emerging markets.
Profitability and growth drives value in SCA. Annual organic growth is estimated to amount to 3–4%, mainly driven by strong growth for incontinence products and increased presence in emerging markets. In addition to organic growth, SCA will grow through complementary company acquisitions.
Higher value-added
SCA endeavours to develop and launch products with a higher value-added content within all segments. Development starts by understanding the needs and preferences of customers and consumers as well as adapting this insight to new products with new functions. This also means that SCA’s role is changing from that of an easily replaced supplier to a strategic partner, which not only produces but also accepts responsibility for product development and complete solutions.
Increased sales in emerging markets
Geographically most of SCA’s sales are concentrated in Europe and North America. As a result of acquisitions and good organic growth an increased portion of sales will take place in markets in Eastern Europe, Latin America and Asia. These prioritized growth markets today account for more than 16% of sales compared with 7% ten years ago.
China is one of SCA's growth markets.